|
Volumn 24, Issue 4, 2002, Pages 356-359
|
Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPSID PROTEIN;
EPSTEIN BARR VIRAL CAPSID ANTIGEN;
EPSTEIN BARR VIRUS EARLY ANTIGEN;
EPSTEIN-BARR VIRAL CAPSID ANTIGEN;
EPSTEIN-BARR VIRUS EARLY ANTIGEN;
IMMUNOGLOBULIN A;
VIRUS ANTIBODY;
VIRUS ANTIGEN;
ADULT;
ARTICLE;
BLOOD;
DIAGNOSTIC ERROR;
EPSTEIN BARR VIRUS;
HUMAN;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
NASOPHARYNX TUMOR;
SENSITIVITY AND SPECIFICITY;
SEROLOGY;
VIROLOGY;
VIRUS INFECTION;
ADULT;
ANTIBODIES, VIRAL;
ANTIGENS, VIRAL;
CAPSID PROTEINS;
DIAGNOSTIC ERRORS;
EPSTEIN-BARR VIRUS INFECTIONS;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOGLOBULIN A;
NASOPHARYNGEAL NEOPLASMS;
SENSITIVITY AND SPECIFICITY;
SEROLOGIC TESTS;
|
EID: 0036637095
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|